Available treatments include local anesthetics, topical capsaicin, topical corticosteroids, hydroxyzine, oxcarbazepine, palmitoylethanolamide and gabapentin. Paravertebral nerve block and botulinum toxin injections may also be helpful. Some patients treated with low concentration topical capsaicin reported pain, burning, or tingling sensations with treatment, and symptoms returned within a month of ceasing treatment. Oxcarbazepine was reported to reduce the severity of symptoms in a few cases. One patient has been treated with "paravertebral nerve blocks, with bupivacaine and methylprednisolone acetate injected into the T3–T4 and T5–T6 intervertebral spaces"  Hydroxyzine has also been used with considerable success in some cases as long as the pills are used daily. High concentration topical capsaicin (8%, Qutenza) have been shown to be highly effective in treating neuropathic itch in some patients (including notalgia paresthetica) as well as in a recent proof-of-concept study.Most recently intradermal injections of botulinum toxin type A (Botox) have been tried with some success. Even though botulinum normally wears off in three to six months, the treatment appears to be long term, and it has been theorised that botulinum type A effects lasting change in pain signaling. Unfortunately, repeated injections have been associated with diminished movement ability of the upper back and arms and its recommendation as a treatment has therefore become less popular. See also
List of cutaneous conditions
Hereditary neuralgic amyotrophy

References

Pleet, A Bernard and Massey, E Wayne, Notalgia Paresthetica, Neurology, Dec 1978; 28: 1310
Pleet, A Bernard and Massey, E Wayne, Letter to the Editor: Notalgia Paresthetica, Neurology, Vol. 29, Issue 4, 528 April 1, 1979


== External links ==
Ametropic amblyopia is a medical condition in which the retina cannot focus on the image of a distant object, a condition often described as reduced visual acuity. This is due to large uncorrected refractive errors in the patients optic system of the eyes. Astigmatism is one of the most frequent causes of ametropic amblyopia. References
Further reading
Moseley, Merrick J., et al. "Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study." British Journal of Ophthalmology 81.11 (1997): 956–961. Cavazos, H.;  et al. (1993). "Ametropic Amblyopia". Strabismus. Informa Plc. 1 (2): 63–67. doi:10.3109/09273979309087719. PMID 21314500. Abraham, S. V. "Bilateral ametropic amblyopia." J Pediatr Ophthalmol Strabismus 1 (1964): 57–61. Werner, D. B., and W. E. Scott. "Amblyopia case reports--bilateral hypermetropic ametropic amblyopia." Journal of pediatric ophthalmology and strabismus 22.5 (1984): 203–205. Moseley, Merrick J;  et al. (1997). "Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study". British Journal of Ophthalmology. BMJ Publishing Group Ltd. 81 (11): 956–961. doi:10.1136/bjo.81.11.956. PMC 1722055. PMID 9505818.